The Smart Investor
    Facebook Instagram
    Tuesday, September 29
    Facebook Instagram LinkedIn
    The Smart Investor
    • Home
    • About
      • About Us
      • Careers
    • Smart Investing
      • Getting Started
      • Investing Strategy
      • Smart Analysis
      • Smart Reads
    • US Stocks
    • Special Free Reports!
    • As Featured on BT
    • Our Services
      • Our Services
      • Subscribe now!
    • Login
    • Cart
    The Smart Investor
    Home»Dividend Stocks»4 Singapore Stocks Bursting Through Their 52-Week Highs: Are They a Buy?
    Dividend Stocks

    4 Singapore Stocks Bursting Through Their 52-Week Highs: Are They a Buy?

    These four stocks are doing well, but should they become a part of your investment portfolio? Let’s find out.
    Royston Y.By Royston Y.May 9, 2025Updated:May 14, 20255 Mins Read
    Facebook Twitter LinkedIn Email WhatsApp
    Q&M (TSI photo by Royston Yang)
    Image credit: The Smart Investor
    Share
    Facebook Twitter LinkedIn Email WhatsApp

    Sifting through the 52-week high share price list is a good way to filter out potential investment candidates.

    Such companies usually announced good news, such as a major acquisition or strong earnings.

    However, investors need to temper this positive sentiment by assessing the risks of the business as well.

    Here are four Singapore stocks that recently touched their 52-week highs. 

    You should review them to see if they deserve a place in your investment portfolio.

    Q&M Dental (SGX: QC7)

    Q&M Dental owns the largest network of private dental clinics in Singapore, with 106 outlets as of 31 December 2024.

    The group also operates 38 dental clinics and a dental supplies and distribution business in Malaysia.

    The share price of the dental group hit its 52-week high of S$0.32 recently, and is up 12.5% year-to-date (YTD).

    Q&M Dental reported a mixed set of earnings for 2024 with total revenue dipping 1% year on year to S$180.7 million.

    Its core dental business saw revenue inch up 0.5% year on year to S$173.8 million, but this was offset by a plunge in diagnostics revenue as COVID-19 testing revenue fell off.

    Net profit climbed 27% year on year to S$14.6 million.

    The group generated a positive free cash flow of S$32 million, up nearly 20% year on year.

    A final dividend of S$0.007 was declared, taking the total dividend for 2024 to S$0.011.

    This dividend was 59% higher than the S$0.0069 paid out for 2023.

    Q&M Dental has proposed to seek a secondary listing in Malaysia’s Bursa Securities as it will allow the group to broaden its investor reach and widen its investor base.

    This listing will also allow the group to tap into additional platforms for future fundraising.

    Parkway Life REIT (SGX: C2PU)

    Parkway Life REIT, or PLife REIT, is a healthcare REIT with a portfolio of three hospitals and medical centres in Singapore, 60 nursing homes in Japan, 11 nursing homes in France, and a medical centre in Malaysia.

    The REIT’s unit price recently touched its 52-week high of S$4.33 and is up 11.7% YTD.

    PLife REIT reported a robust financial performance for the first quarter of 2025 (1Q 2025).

    Gross revenue and net property income rose 7.3% and 7.5% year on year, respectively, to S$39 million and S$36.8 million.

    The higher revenue was contributed by the maiden revenue recognition from the acquisition of the French nursing homes and one nursing home in Japan.

    The Singapore properties’ lease step-up arrangement also helped gross revenue increase for the quarter.

    Distribution per unit inched up 1.3% year on year to S$0.0384.

    The REIT has moderate gearing of 36.1% and a low all-in debt cost of just 1.5%.

    90% of the REITs interest rate exposure is hedged, helping it to mitigate higher finance costs.

    Meanwhile, PLife REIT also announced the divestment of its entire Malaysia portfolio after the end of 1Q 2025 at RM 20.09 million, booking an estimated gain (before tax) of S$0.1 million.

    The divestment price was 4.6% above the independent valuation of two valuers as of 31 December 2024.

    DFI Retail Group (SGX: D01)

    DFI Retail Group is a pan-Asian retailer operating over 10,700 outlets across Asia in key retail divisions such as food, home and furnishings, health and beauty, and restaurants.

    The blue-chip group’s share price touched its 52-week high of US$2.74 and is up nearly 18% YTD.

    DFI Retail Group reported a mixed set of earnings for 2024, with revenue dipping 3% year on year to US$8.9 billion.

    Underlying net profit, however, climbed 30% year on year to US$201 million.

    The total dividend for 2024 shot up 31% year on year to US$0.105.

    The group recently sold off its Singapore Cold Storage and Giant stores to Malaysia’s Macrovalue, a Southeast Asian retail conglomerate, for S$125 million.

    Management aims to consolidate its position in markets such as Hong Kong, where the group is strong, while expanding key businesses such as Health and Beauty and Convenience.

    The group is also targeting to expand its omnichannel strategy to capture more market share.

    Oiltek International (SGX: HQU)

    Oiltek provides a comprehensive range of refinery processes and engineering solutions across different sectors of the vegetable oils industry value chain.

    The group has successfully designed, built, and commercialised plants in more than 37 countries on five continents.

    Oiltek’s share price hit its 52-week high of S$2.10 recently and is now up 66% YTD (after adjusting for the bonus share issue – details below).

    For 2024, the group reported a 14.5% year-on-year increase in revenue to RM 230.3 million.

    Net profit soared 55% year on year to RM 29.6 million.

    Oiltek proposed a final dividend of S$0.018, bringing its full year (2024) dividend to S$0.027.

    A total of RM 207 million of new orders was secured for 2024, bringing the group’s order book to RM 354.9 million as of 31 December 2024.

    In line with the strong results, Oiltek announced a bonus share issue of two new bonus shares for every share held by shareholders.

    Just last month, the group announced that it had secured RM 61.9 million of new orders across global markets from Africa, the Americas, Thailand, Indonesia, and Malaysia.

    With these new contracts, its order book stood at approximately RM 402.4 million, which will be fulfilled in the next 18 to 24 months.

    Big Tech is spending hundreds of billions on AI,  and the ripple effects are just beginning. Our new investor guide shows how AI is changing the way companies generate revenue, structure their business models, and gain an edge. Even if you already know the major players, this report reveals something far MORE important: The why and how behind their moves, and what it means for your portfolio. Download your free report now.

    Follow us on Facebook and Telegram for the latest investing news and analyses!

    Disclosure: Royston Yang does not own shares in any of the companies mentioned.

    Yahoo
    Share. Facebook Twitter LinkedIn Email WhatsApp

    Related Posts

    Can You Eat Your Dividends? (The Curry Puff Strategy)

    September 29, 2026
    DBS OCBC or UOB

    DBS, OCBC or UOB — Which Singapore Bank Stock Actually Made You the Most Money?

    September 29, 2026
    MLT Mapletree Logistics Hub, Toh Guan

    Dividend Trap or Bargain? How to Tell When a High Yield Is Misleading

    September 29, 2026
    Facebook Instagram LinkedIn Telegram YouTube TikTok
    • Careers
    • Disclaimer & Privacy Policy
    • Advertising & Media Enquiries
    • Subscription Terms of Service
    © 2026 The Smart Investor. All Rights Reserved. The Smart Investor, thesmartinvestor.com.sg, an investment education website managed by The Investing Hustle Pte Ltd (Company Reg No. 201933459Z) is not licensed or otherwise regulated by the Monetary Authority of Singapore, and in particular, is not licensed or regulated to carry on business in providing any financial advisory service. Accordingly, any information provided on this site is meant purely for informational and investor educational purposes and should not be relied upon as financial advice. No information is presented with the intention to induce any reader to buy, sell, or hold a particular investment product or class of investment products. Rather, the information is presented for the purpose and intentions of educating readers on matters relating to financial literacy and investor education. Accordingly, any statement of opinion on this site is wholly generic and not tailored to take into account the personal needs and unique circumstances of any reader. The Smart Investor does not recommend any particular course of action in relation to any investment product or class of investment products. Readers are encouraged to exercise their own judgment and have regard to their own personal needs and circumstances before making any investment decision, and not rely on any statement of opinion that may be found on this site.

    Type above and press Enter to search. Press Esc to cancel.